Jiaxing Maternity and Child Health Care Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03520439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

First Affiliated Hospital of Jiaxing University | Jiaxing First Hospital | Jiaxing Maternity and Child Health Care Hospital | Jiaxing University Affiliated Women and Children Hospital | The First Hospital of Jiaxing

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Phase 3 Trials (5)

borneol (1 trial)

carboplatin (paraplatin) (1 trial)

epoetin (Epogen) (1 trial)

mifepristone (mifeprex) (2 trials)

paclitaxel (taxol) (1 trial)

Drugs in Phase 2 Trials (2)

anlotinib (1 trial)

docetaxel (taxotere) (1 trial)

Drugs in Phase 1 Trials (1)

triptorelin (Trelstar) (1 trial)

Drugs in Other Trials (1)

venlafaxine (effexor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenomyosis (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 11